Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duluning versus Gehuazhi in type 2 diabetes mellitus
ChiCTR2000040939Phase 4Completed
- Sponsor
- Beijing Hospital
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Beijing Hospital. Primary endpoint: HbA1c. Started May 2017; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000040939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040939.